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The evolution of methods to assess genotoxicity of test compounds is thought to be one of the important subjects
in The Japanese Environmental and Mutagen Society (JEMS). In 1970, the Ministry of Education of Japan (at that
time) organized a research group (Organizer: Y. Tazima, National Institute of Genetics), and started a systematic
research on the genotoxic effects induced by chemical substances. Considering the importance of this issue
through the outcomes of the research group, JEMS was established in 1972, and President Tazima organized the
1st annual meeting in the August in Tokyo with the participation of experts in this field working in national
institutes, universities and others in Japan. The discovery that food additives possessed genotoxic potential
triggered various scientific activities in the field of genotoxicity. Another important point was the correlation
between genotoxicity and carcinogenicity, in which the establishment of the reverse mutation assay played an
important role. Other critical factors, such as side effects of drugs, occupational cancer, and environmental pollution
due to genotoxic chemicals, emphasized the importance of genotoxicity tests for human safety. The tests
performed to assess genotoxicity from 1960s to 1980s will be described to understand that many different
genotoxic methodologies were discussed in these periods.
Keywords: Genotoxicity test methods, Food additives, AF-2Introduction
Food additives and genotoxicity tests are interrelated, in
which the most important food additive is 2-(2-furyl)-3-
(5-nitro-2-furyl) acrylamide (AF-2). Initially, I would like
to introduce the words written by M. Ishidate, Jr. who was
the first Director of the Division of Genetics and Muta-
genesis, National Institute of Health Sciences, Tokyo,
Japan: “The safety of AF-2 used in tofu (bean curd) as a
germicide was questioned in Japan a few years ago.
Initially, geneticists pointed out that the AF-2 was muta-
genic in microorganisms, such as bacteria, and was clasto-
genic in cultured human lymphocytes. Subsequently, its
carcinogenicity in mice was demonstrated, after which
administrative measures were taken to regulate the use of
AF-2 [1].” In 1974, AF-2 was officially prohibited for use.
Ishidate wrote “a few years ago,” although his document
was published seven years after the prohibition, suggesting
how great the impact of the AF-2 issue was.
At the beginning of 1970s, Prof. B. N. Ames developed,
as a new test system for genotoxicity, the reverse mutationCorrespondence: toshi_sofu@jcom.zaq.ne.jp
Formerly National Institute of Health Sciences, Tokyo, Japan
© The Author(s). 2017 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeassay using Salmonella typhimurium, the so-called “Ames
test.” His research group examined approximately 300
substances using Ames test and found a high correlation
between carcinogenicity and genotoxicity, indicating that
this test could be used for the screening of carcinogenic
chemicals as it consumed less time. However, AF-2 ini-
tially showed negative results in Ames test with bacterial
strains such as TA1535 and TA1538. Therefore, new and
more sensitive test strains were constructed, such as
TA100 and TA98, by introducing the plasmid pKM101
into TA1535 and TA1538 strains, respectively. Both
TA100 and TA98 strains showed positive results with AF-
2, particularly in TA100 [2]. The reason of the high sensi-
tivity of TA100 is mucAB genes on pKM101 although they
were not well studied at that time. About thirty years later,
it was revealed that mucAB genes encode a DNA polymer-
ase R1 related to translesion DNA synthesis, which causes
mutation due to mis-incorporation of bases opposite
DNA lesions generated by chemicals, such as AF-2.
Consequently, five to six tester strains, including TA100
and TA98, were used as standards in routine testing for
the reverse mutation assay. The relationship betweenle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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tioned above. I would like to describe an outline of the
evolution of genotoxicity tests at the initial stage (1960’s to
1980’s).
Outline of genotoxicity tests in the initial stage
Around 1945, certain chemicals were recognized to possess
genotoxic potential, but the situation at such a preliminary
stage is omitted here. In 1965, Food Sanitation Council in
Japan published Standards for Designation of Food Addi-
tives and for Revision of Use Regulation of Food Additives,
in which only two tests, namely, acute toxicity test and
chronic toxicity test were adopted for toxicity evaluation [3].
One of the notable food additives prior to the emer-
gence of AF-2 was sodium cyclohexylsulfamate (“cyclo”).
This substance, which was approved in 1956 as a food
additive in Japan, was used worldwide. In 1968, however,
the Food and Drug Administration (FDA) of United State
announced that some metabolites derived from “cyclo”
were responsible for chromosomal damage in experimen-
tal animals. In 1969, US government announced that
“cyclo” was carcinogenic in experimental animals and pro-
hibited its use [4]. Back again, in 1968, the Ministry of
Health and Welfare (MHW) of Japan had organized the
Welfare Science Research group and had started investi-
gating the toxicity of cyclohexylamine, one of the metabo-
lites of “cyclo”. Cyclohexylamine was found to induce
chromosomal aberrations in cultured human cells, which
confirmed the previous report by FDA. In 1969, because
of its carcinogenic potential obtained in experimental ani-
mals in US, the use and sale of “cyclo” as a food additive
was prohibited by the ministerial ordinance of MHW [4].
In 1973, the issue of AF-2 occurred by findings that AF-
2 induced mutagenicity and DNA damage in microorgan-
isms and clastogenicity in cultured human lymphocytes
and rat bone marrow cells. The use of AF-2 was prohib-
ited officially in 1974 following the demonstration of its
carcinogenicity in mice. In response to this, several
administrative correspondences were published, including
the Interim Standard of Genetic Safety Evaluation of Food
Additives issued by the Joint Committee of Toxicity and
Food Additives in the Food Sanitation Council. The geno-
toxicity tests adopted in this standard are as follows [5]:
1. First screening test
More than two test systems using microorganisms
with different characteristics
2. Second screening test
a. Examination of chromosomal aberrations using
cultured mammalian cells
b. Examination of sex-linked recessive lethal mutations
using Drosophila or recessive mutations based on
specific-locus method using silkworms
3. In vivo test using mammalsa. Metabolism, and host-mediated assay
b. In vivo chromosomal aberration test
c. Dominant lethal test
d. Specific-locus test using mice
e. BiotransformationAccording to the standard, the second screening test
should be performed on those substances that show posi-
tive results in the first screening test or on those substances
that are judged very important (high production volume,
wide range of use, and so on), even though negative results
were obtained. In the second screening test, chromosomal
aberration test using cultured mammalian cells and/or gene
mutation tests using insects should be conducted. When
substances show positive results in the second screening
test or are judged very important, even though negative
results were obtained in the second screening test, in vivo
tests using mammals should be performed [5].
According to the implementation guidance of this stand-
ard, the reverse mutation assay using S. typhimurium
TA1535, TA1536, TA1537 and TA1538 or Escherichia coli
WP2 should be conducted in the first screening test, and
test organisms such as E. coli Sd-4, Saccharomyces cerevi-
ciae 1765-5A and Neurospora crassa ad-3 could be in-
cluded. In addition, the DNA repair (damage) test using
Bacillus subtilis rec+/rec− (Rec-assay), E. coli pol+/pol−, S.
typhimurium hrc+/hrc− are indicated, and the metabolic
activation system using liver homogenates from 2 or 3
mammals such as rats and mice should be adopted in the
above tests. For the second screening tests and in vivo tests,
some practical recommendations are made in the guide-
lines, for example, as the use tester strains for the mouse
specific-locus test, the PW strain developed by Kiyoshi
Tutikawa of the National Institute of Genetics of Japan is
described, in addition to the PT strain developed by W. L.
Russell and the HT strain developed by M. F. Lyon [5].
In 1973, the MHW founded Carcinogenicity Research
Group for technical development of short-term screening
tests of chemical carcinogens. In 1975, the research group
of Technical Development of Short-Term Screening Tests
of Chemical Carcinogens by Utilization of Genotoxicity
Tests” (Organizer: T. Kawachi, National Cancer Institute)
and the research group of Animal Experiments of
Carcinogenicity on Genotoxic Chemicals” (Organizer: S.
Odashima, National Institute of Health Sciences) was
organized. About 30 substances were evaluated by the
Short-Term Screening Tests group for a period of one
year, and genotoxicity tests primary used by this group are
as follows [6]:
1. Tests using microorganisms
a. DNA repair test using B. subtilis (rec+/rec−)
(including metabolic activation) and E. coli
(WP2, WP100) (liquid and solid method)
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(TA100, TA98 and TA1537) (including metabolic
activation)
2. Tests using mammalian cells
a. Chromosomal aberration test using Chinese
hamster cells (CHL, Don) (including metabolic
activation) and human diploid cells (HE2144)
b. Sister chromatid exchange test using Chinese
hamster cells (Don) (including metabolic
activation) and human diploid cells (HE2144)
c. Micronucleus test using cultured mammalian cells
d. Chromosomal aberration test using rat bone
marrow cells
3. Tests using insects
a. Specific-locus test using silkworms
b. Test (M-5 method) using Drosophila
According to the guidelines, when test substances
showed positive or inconclusive results in the screening
group, they were examined by the carcinogenicity test
using experimental animals, according to their social de-
mand or production volume. In this way, the usefulness
of diverse genotoxicity tests was investigated.
In 1979, the Carcinogenicity Research Group of the
MHW tried making a tentative selection from many
genotoxicity tests based on the data obtained previously
and the trends in overseas as follows [1, 7]:
1. Feasible tests
a. Reverse mutation assay using bacteria
b. DNA repair test using bacteria
c. Chromosomal aberration test using cultured
mammalian cells
d. Micronucleus test using mouse bone marrow
cells
e. Dominant lethal test using mice or rats.
2. Tests with requirement for further considerations
a. Gene mutation test using bacteria
b. Gene mutation test using insects
c. Gene mutation test using cultured mammalian
cells
d. Sister chromatid exchange test using mammalian
cells
e. Unscheduled DNA synthesis test using
mammalian cells
f. Specific-locus test using mice
g. Reciprocal translocation test using mice or rats
h. Spot test using mice
3. Tests with technical difficulties
a. Chromosomal aberration test using insects
b. Mitotic recombination or gene conversion tests
using yeasts
c. Cell transformation test using cultured
mammalian cellsGenotoxicity tests used to establish guidelines
The drug for human use is one of the representatives
among various chemical substances. The Thalidomide
case in 1961 led to reviewing and strengthening the
pharmaceutical regulatory system as well as the guidelines
for testing the reproductive toxicity of drugs, which were
established in 1965. In 1967, the Basic Policies for
Approval to Manufacture Drugs was issued in the form of
a notification by the Director General of the Pharmaceut-
ical Affairs Bureau, the MHW [8]. In 1980, the Pharma-
ceutical Affairs Law was drastically revised, and according
to the classification of new drugs, nine different toxicity
tests were required, including the genotoxicity test [8].
However, the protocols were not defined, and many re-
quests were issued by Japan and other countries to clarify
the guidelines for toxicity testing of drugs.
In 1982, the MHW organized a research group of ex-
perts to establish the guidelines for toxicity tests of drugs
and undertook a review of the guidelines in Japan, referring
to those of other countries [8]. In 1983, draft guidelines for
general toxicity tests (acute, subacute, and chronic), car-
cinogenicity tests, reproductive tests, and genotoxicity tests
were published by the MHW. In 1984, the draft guidelines
were revised based on the opinions of those concerned
with these tests in Japan and in other countries, and the
Guidelines for Toxicity Studies of Drugs were established
in the form of a notification from the Director General.
The tests incorporated a battery of genotoxicity tests as fol-
lows: reverse mutation assay using bacteria, chromosomal
aberration test using cultured mammalian cells, and micro-
nucleus test using rodents [8]. The number of genotoxicity
tests evaluated initially in Japan exceeded 10, of which five
were selected as feasible tests that could be performed in
Japan. Finally, three tests were chosen based on a discus-
sion of the outcomes of various collaborative studies.
A correlation between chemicals and occupational cancer
attracted attention since 1965 and became a public health
concern in 1975. Therefore, the Industrial Safety and
Health Law was established and enforced by Ministry of
Labor (at that time), and safety measures for protection of
people from occupational diseases were implemented. Ac-
cording to this law, prior to new chemicals being intro-
duced into the workplace, these compounds should first be
examined for adverse effects, and commensurate preventive
measures should be performed. However, sufficient effect-
ive outcomes were not achieved because a definite regula-
tory obligation was not offered to companies. Therefore,
the Industrial Safety and Health Law was revised and
enforced in 1977 and implemented in 1979 [9]. The revised
law required companies to examine the adverse effects of
new chemicals and report them to the Ministry of Labor.
The law requires that the genotoxicity test or an equiva-
lent or superior test should be performed to evaluate the
chemical’s carcinogenicity, instead of the carcinogenicity
Fig. 1 Evolution outline of genotoxicity test methods. *MHW: Ministry of Health and Welfare, which was changed to Ministry of Health, Labour,
and Welfare since 2001, based on the reorganization
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performed the genotoxicity tests, and their outcomes were
reported to the Ministry of Labor. The Ministry of Labor
obtained opinion from experts regarding the reverse mu-
tation assay as the most appropriate test, because the
assay was found to be quick, simple and reproducible.
Therefore, in 1979, the Ministry of Labor issued the Stan-
dards for Genotoxicity Tests using Microorganisms [9].
According to the knowledge accumulated using this assay
and the Guidelines for the Testing of Chemicals and Good
Laboratory Practice by OECD, the Ministry of Labor
revised the standard according to opinions issued by meet-
ings of experts and released the Standards for Mutagenicity
Tests using Microorganism in 1985 [10].
During 1970s, environmental pollution caused by PCB
became a serious problem. This issue led to the recon-
sideration of awareness of chemical safety, and the Acton the Evaluation of Chemical Substances and Regula-
tion of Their Manufacture, was enforced in 1973 as the
world’s first and implemented in 1974. Chemicals such
as PCB with high bioaccumulation, non-biodegradation,
and chronic toxicity should be designated as the Speci-
fied Chemical Substance for the implementation of re-
quired regulations.
The list of tests indicated at first did not include the gen-
otoxicity test that was added in 1984 without any explan-
ation of test protocols [11]. Moreover, the contamination of
groundwater with trichloroethylene occurred in Japan, and
this chemical was out of subjects to the regulation of this
law, requiring the correspondence for such chemicals. To
response to these changing circumstances, the law was
drastically revised, which was implemented in 1987 [11].
According to this revision, the determination of the Desig-
nated Chemical Substance with low bioaccumulation but
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be performed simultaneously. Furthermore, the genotoxi-
city test and 28-day repeat-dose toxicity test were intro-
duced for the determination of the Designated Chemical
Substances. The reverse mutation assay using bacteria and
chromosomal aberration test using cultured mammalian
cells were adopted as the genotoxicity test, and these tests
together with the 28-day repeat-dose toxicity test using ex-
perimental animals were generally referred as the Screening
Toxicity Tests of New Chemical Substances.
Consideration of regulations for the substances such
as agricultural chemicals, of which categories had been
already regulated by other laws, was omitted.
Conclusion
Outlines of the evolution of genotoxicity test methods are
described above and essential items are shown in Fig. 1. In
the early stages, various tests were evaluated, and the
selection of appropriate ones was difficult considerably.
Information on this topic in countries other than Japan is
not included here; however, this information has signifi-
cantly affected the selection of suitable tests in Japan.
Accumulation of data is ongoing, and based on such data,
revisions of test methodologies are being performed, and
new tests are being established. Initially, the genotoxicity
test was considered as the screening method for evaluat-
ing chemical carcinogens; however, the significance of
genotoxicity is the focus of attention, because the mecha-
nisms underlying their toxicological effects are becoming
better understood. Moreover, discussions concerning how
we can correlate genotoxicity and risk assessment of
humans are ongoing. Accordingly, the degree of require-
ments are higher than before, and it is, therefore, neces-
sary to improve test methodologies, that is, the evolution
of genotoxicity test methods will continue.
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